Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Mutation of the palmitoylation site of estrogen receptor α in vivo reveals tissue-specific roles for membrane versus nuclear actions.

Adlanmerini M, Solinhac R, Abot A, Fabre A, Raymond-Letron I, Guihot AL, Boudou F, Sautier L, Vessières E, Kim SH, Lière P, Fontaine C, Krust A, Chambon P, Katzenellenbogen JA, Gourdy P, Shaul PW, Henrion D, Arnal JF, Lenfant F.

Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):E283-90. doi: 10.1073/pnas.1322057111. Epub 2013 Dec 26.

2.

Estren behaves as a weak estrogen rather than a nongenomic selective activator in the mouse uterus.

Hewitt SC, Collins J, Grissom S, Hamilton K, Korach KS.

Endocrinology. 2006 May;147(5):2203-14. Epub 2006 Feb 9.

PMID:
16469803
3.

The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activation.

Abot A, Fontaine C, Buscato M, Solinhac R, Flouriot G, Fabre A, Drougard A, Rajan S, Laine M, Milon A, Muller I, Henrion D, Adlanmerini M, Valéra MC, Gompel A, Gerard C, Péqueux C, Mestdagt M, Raymond-Letron I, Knauf C, Ferriere F, Valet P, Gourdy P, Katzenellenbogen BS, Katzenellenbogen JA, Lenfant F, Greene GL, Foidart JM, Arnal JF.

EMBO Mol Med. 2014 Oct;6(10):1328-46. doi: 10.15252/emmm.201404112.

4.

The Activation Function-1 of Estrogen Receptor Alpha Prevents Arterial Neointima Development Through a Direct Effect on Smooth Muscle Cells.

Smirnova NF, Fontaine C, Buscato M, Lupieri A, Vinel A, Valera MC, Guillaume M, Malet N, Foidart JM, Raymond-Letron I, Lenfant F, Gourdy P, Katzenellenbogen BS, Katzenellenbogen JA, Laffargue M, Arnal JF.

Circ Res. 2015 Oct 9;117(9):770-8. doi: 10.1161/CIRCRESAHA.115.306416. Epub 2015 Aug 27.

5.

Role of ERα in the Effect of Estradiol on Cancellous and Cortical Femoral Bone in Growing Female Mice.

Vinel A, Hay E, Valera MC, Buscato M, Adlanmerini M, Guillaume M, Cohen-Solal M, Ohlsson C, Lenfant F, Arnal JF, Fontaine C.

Endocrinology. 2016 Jun;157(6):2533-44. doi: 10.1210/en.2015-1994. Epub 2016 Apr 22.

PMID:
27105385
6.

Estrogen receptor α AF-2 mutation results in antagonist reversal and reveals tissue selective function of estrogen receptor modulators.

Arao Y, Hamilton KJ, Ray MK, Scott G, Mishina Y, Korach KS.

Proc Natl Acad Sci U S A. 2011 Sep 6;108(36):14986-91. doi: 10.1073/pnas.1109180108. Epub 2011 Aug 22.

7.

Protective Hematopoietic Effect of Estrogens in a Mouse Model of Thrombosis: Respective Roles of Nuclear Versus Membrane Estrogen Receptor α.

Valéra MC, Fontaine C, Lenfant F, Cabou C, Guillaume M, Smirnova N, Kim SH, Chambon P, Katzenellenbogen JA, Katzenellenbogen BS, Payrastre B, Arnal JF.

Endocrinology. 2015 Nov;156(11):4293-301. doi: 10.1210/en.2015-1522. Epub 2015 Aug 17.

8.

The AF-1 activation function of estrogen receptor α is necessary and sufficient for uterine epithelial cell proliferation in vivo.

Abot A, Fontaine C, Raymond-Letron I, Flouriot G, Adlanmerini M, Buscato M, Otto C, Bergès H, Laurell H, Gourdy P, Lenfant F, Arnal JF.

Endocrinology. 2013 Jun;154(6):2222-33. doi: 10.1210/en.2012-2059. Epub 2013 Apr 11.

PMID:
23580568
9.

Membrane-localized estrogen receptor α is required for normal organ development and function.

Pedram A, Razandi M, Lewis M, Hammes S, Levin ER.

Dev Cell. 2014 May 27;29(4):482-90. doi: 10.1016/j.devcel.2014.04.016.

10.

Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice.

Chambliss KL, Wu Q, Oltmann S, Konaniah ES, Umetani M, Korach KS, Thomas GD, Mineo C, Yuhanna IS, Kim SH, Madak-Erdogan Z, Maggi A, Dineen SP, Roland CL, Hui DY, Brekken RA, Katzenellenbogen JA, Katzenellenbogen BS, Shaul PW.

J Clin Invest. 2010 Jul;120(7):2319-30. doi: 10.1172/JCI38291. Epub 2010 Jun 23.

11.

Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol.

Acconcia F, Ascenzi P, Bocedi A, Spisni E, Tomasi V, Trentalance A, Visca P, Marino M.

Mol Biol Cell. 2005 Jan;16(1):231-7. Epub 2004 Oct 20.

12.

GPR30 activation opposes estrogen-dependent uterine growth via inhibition of stromal ERK1/2 and estrogen receptor alpha (ERα) phosphorylation signals.

Gao F, Ma X, Ostmann AB, Das SK.

Endocrinology. 2011 Apr;152(4):1434-47. doi: 10.1210/en.2010-1368. Epub 2011 Feb 8.

13.

Palmitoylation regulates 17β-estradiol-induced estrogen receptor-α degradation and transcriptional activity.

La Rosa P, Pesiri V, Leclercq G, Marino M, Acconcia F.

Mol Endocrinol. 2012 May;26(5):762-74. doi: 10.1210/me.2011-1208. Epub 2012 Mar 22.

PMID:
22446104
14.

Estrogen hormone physiology: reproductive findings from estrogen receptor mutant mice.

Hamilton KJ, Arao Y, Korach KS.

Reprod Biol. 2014 Mar;14(1):3-8. doi: 10.1016/j.repbio.2013.12.002. Epub 2013 Dec 21. Review.

15.

Plasma membrane estrogen receptors exist and functions as dimers.

Razandi M, Pedram A, Merchenthaler I, Greene GL, Levin ER.

Mol Endocrinol. 2004 Dec;18(12):2854-65. Epub 2004 Jul 1.

PMID:
15231873
16.

Developmental phenotype of a membrane only estrogen receptor alpha (MOER) mouse.

Pedram A, Razandi M, Kim JK, O'Mahony F, Lee EY, Luderer U, Levin ER.

J Biol Chem. 2009 Feb 6;284(6):3488-95. doi: 10.1074/jbc.M806249200. Epub 2008 Dec 3.

17.

Roles of transactivating functions 1 and 2 of estrogen receptor-alpha in bone.

Börjesson AE, Windahl SH, Lagerquist MK, Engdahl C, Frenkel B, Movérare-Skrtic S, Sjögren K, Kindblom JM, Stubelius A, Islander U, Antal MC, Krust A, Chambon P, Ohlsson C.

Proc Natl Acad Sci U S A. 2011 Apr 12;108(15):6288-93. doi: 10.1073/pnas.1100454108. Epub 2011 Mar 28.

18.

Identification of a structural determinant necessary for the localization and function of estrogen receptor alpha at the plasma membrane.

Razandi M, Alton G, Pedram A, Ghonshani S, Webb P, Levin ER.

Mol Cell Biol. 2003 Mar;23(5):1633-46.

19.

An estrogen receptor-alpha knock-in mutation provides evidence of ligand-independent signaling and allows modulation of ligand-induced pathways in vivo.

Sinkevicius KW, Burdette JE, Woloszyn K, Hewitt SC, Hamilton K, Sugg SL, Temple KA, Wondisford FE, Korach KS, Woodruff TK, Greene GL.

Endocrinology. 2008 Jun;149(6):2970-9. doi: 10.1210/en.2007-1526. Epub 2008 Mar 13.

20.

Activation function 2 (AF2) of estrogen receptor-alpha is required for the atheroprotective action of estradiol but not to accelerate endothelial healing.

Billon-Galés A, Krust A, Fontaine C, Abot A, Flouriot G, Toutain C, Berges H, Gadeau AP, Lenfant F, Gourdy P, Chambon P, Arnal JF.

Proc Natl Acad Sci U S A. 2011 Aug 9;108(32):13311-6. doi: 10.1073/pnas.1105632108. Epub 2011 Jul 25.

Supplemental Content

Support Center